SYS-6036

N/A

Report date: 2025/08/25 16:04:22

Base Information

Drug NameSYS-6036
Drug Alias NameSYS6036SYS-6036
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMicrosatellite instability-high cancerMismatch Repair Deficient CancerUterine Cervical Neoplasms +[13] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJushi Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJushi Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsMicrosatellite instability-high cancerMismatch Repair Deficient CancerUterine Cervical Neoplasms +[13] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A